Đang chuẩn bị liên kết để tải về tài liệu:
The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

To quantify the financial cost of pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc). Methods: Healthcare use was captured through data linkage, wherein clinical data for SSc patients enrolled in the Australian Scleroderma Cohort Study were linked with hospital, emergency department (ED) and ambulatory care databases (MBS) for the period 2008–2015. |

TÀI LIỆU LIÊN QUAN

The economic burden of bronchiectasis – known and unknown: A systematic review

The economic burden of medical treatment of children with asthma in China

The cost of lost productivity due to premature cancer-related mortality: An economic measure of the cancer burden

Health-economic burden of dementia in South Korea

The economic burden of systemic sclerosis related pulmonary arterial hypertension in Australia

The projected burden of primary total knee and hip replacement for osteoarthritis in Australia to the year 2030

Clinical, economic, and humanistic burden of asthma in Canada: A systematic review

Burden of early, advanced and metastatic breast cancer in The Netherlands

Burden of asthma with elevated blood eosinophil levels

Addressing obesity in the management of knee and hip osteoarthritis – weighing in from an economic perspective
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.